Lymphocytes, neuropeptides, and genes involved in alopecia areata.

PubWeight™: 1.56‹?› | Rank: Top 4%

🔗 View Article (PMC 1934574)

Published in J Clin Invest on August 01, 2007

Authors

Amos Gilhar1, Ralf Paus, Richard S Kalish

Author Affiliations

1: Skin Research Laboratory, The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology and Flieman Medical Center, Haifa, Israel.

Associated clinical trials:

Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic Evaluation | NCT03473600

Articles citing this

Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature (2010) 2.85

A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin. J Invest Dermatol (2012) 2.05

Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77

Management of alopecia areata. BMJ (2010) 1.25

What causes alopecia areata? Exp Dermatol (2013) 1.14

The pathogenesis of primary cicatricial alopecias. Am J Pathol (2010) 1.09

Genetic basis of alopecia areata: a roadmap for translational research. Dermatol Clin (2012) 1.03

An extraordinary colocalization of alopecia areata and vitiligo. Int J Trichology (2010) 0.99

Renbok phenomenon and contact sensitization in a patient with alopecia universalis. Arch Dermatol (2010) 0.96

Exomic sequencing of immune-related genes reveals novel candidate variants associated with alopecia universalis. PLoS One (2013) 0.83

Comparative study of intralesional steroid injection and cryotherapy in alopecia areata. Niger Med J (2016) 0.83

Transient Efficacy of Tofacitinib in Alopecia Areata Universalis. Case Rep Dermatol (2016) 0.81

Efficacy and safety of methotrexate in alopecia areata. An Bras Dermatol (2014) 0.81

Association analysis of the HLA-C gene in Japanese alopecia areata. Immunogenetics (2013) 0.80

Diphencyprone induced vitiligo: a case report. Case Rep Med (2012) 0.79

Vitiligo and alopecia areata: apples and oranges? Exp Dermatol (2013) 0.79

Hair regrowth in alopecia areata patients following Stem Cell Educator therapy. BMC Med (2015) 0.79

Association between interleukin 18 polymorphisms and alopecia areata in Koreans. J Interferon Cytokine Res (2014) 0.79

Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model. Cell Stress Chaperones (2011) 0.78

The juvenile alopecia mutation (jal) maps to mouse Chromosome 2, and is an allele of GATA binding protein 3 (Gata3). BMC Genet (2013) 0.77

Dietary vitamin A regulates wingless-related MMTV integration site signaling to alter the hair cycle. Exp Biol Med (Maywood) (2014) 0.76

Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies? Cancer Biol Ther (2015) 0.75

Videocapillaroscopic alterations in alopecia areata. Biomed Res Int (2013) 0.75

CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata. J Immunol (2016) 0.75

Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies. Autoimmun Rev (2016) 0.75

Angiotensin converting enzyme activity in alopecia areata. Enzyme Res (2014) 0.75

Cutis verticis gyrata and alopecia areata: a synchronous coincidence? Yonsei Med J (2010) 0.75

The role of selectins in alopecia areata. Postepy Dermatol Alergol (2015) 0.75

T-cell reconstitution after thymus xenotransplantation induces hair depigmentation and loss. J Invest Dermatol (2013) 0.75

Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol (2015) 0.75

Factors Associated with Severity of Alopecia Areata. Ann Dermatol (2017) 0.75

Association among Thyroid Dysfunction, Asthma, Allergic Rhinitis and Eczema in Children with Alopecia Areata. Open Access Maced J Med Sci (2017) 0.75

A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat. PLoS One (2017) 0.75

Articles cited by this

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med (2004) 8.98

NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med (2007) 3.99

Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med (2004) 2.73

See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol (2006) 2.62

Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol (2005) 2.49

Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc (1995) 1.99

TGF-beta: a mobile purveyor of immune privilege. Immunol Rev (2006) 1.90

Neuroimmunology of stress: skin takes center stage. J Invest Dermatol (2006) 1.72

[Turning white overnight, is it possible?]. Ned Tijdschr Geneeskd (1993) 1.61

Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol (2005) 1.58

Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol (2006) 1.56

Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am J Hum Genet (2007) 1.55

Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). J Invest Dermatol (2007) 1.54

Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol (1998) 1.46

Epidemiology and genetics of alopecia areata. Clin Exp Dermatol (2002) 1.45

Alopecia areata. Int J Dermatol (2007) 1.45

The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol (2000) 1.42

Adult-onset Alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model. J Invest Dermatol (2004) 1.38

Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev (2005) 1.36

Histopathologic features of alopecia areata: a new look. Arch Dermatol (2003) 1.34

The pattern and profile of alopecia areata in Singapore--a study of 219 Asians. Int J Dermatol (2002) 1.33

Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol (2006) 1.33

Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol Rev (2006) 1.27

Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest (1998) 1.27

Generation and cyclic remodeling of the hair follicle immune system in mice. J Invest Dermatol (1998) 1.22

A 'hairy' privilege. Trends Immunol (2005) 1.21

Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans. J Invest Dermatol (2002) 1.17

Alopecia areata induced in C3H/HeJ mice by interferon-gamma: evidence for loss of immune privilege. J Invest Dermatol (2005) 1.13

Hair growth inhibition by psychoemotional stress: a mouse model for neural mechanisms in hair growth control. Exp Dermatol (2006) 1.13

The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J Investig Dermatol Symp Proc (1999) 1.13

Interferon-gamma-deficient mice are resistant to the development of alopecia areata. Br J Dermatol (2006) 1.10

A historical perspective on immunological privilege. Immunol Rev (2006) 1.08

Characterization of hair follicle antigens targeted by the anti-hair follicle immune response. J Investig Dermatol Symp Proc (2003) 1.04

HLA class II antigen associations help to define two types of alopecia areata. J Am Acad Dermatol (1995) 1.03

Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice. J Invest Dermatol (2001) 1.02

Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice. J Investig Dermatol Symp Proc (1999) 1.02

Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol (2004) 1.01

Immunology of the hair follicle: a short journey into terra incognita. J Investig Dermatol Symp Proc (1999) 1.01

Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition. J Mol Med (Berl) (2005) 1.01

Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J Invest Dermatol (2005) 0.99

Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles. Br J Dermatol (2005) 0.98

T cell subpopulations in alopecia areata. J Am Acad Dermatol (1984) 0.97

Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med (1995) 0.97

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome: time to review diagnostic criteria? J Clin Endocrinol Metab (2003) 0.96

The pathogenesis of alopecia areata. Dermatol Clin (1996) 0.96

The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. J Am Acad Dermatol (2001) 0.96

The DEBR rat: an animal model of human alopecia areata. Br J Dermatol (1991) 0.95

Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. Am J Pathol (2004) 0.95

Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice. Arch Dermatol (2002) 0.95

Distribution of major histocompatibility antigens in normal skin. Br J Dermatol (1983) 0.95

Diphencyprone for the treatment of alopecia areata: more data and new aspects. Arch Dermatol (2002) 0.94

Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Br J Dermatol (2006) 0.91

Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells. J Invest Dermatol (2002) 0.91

Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata. Hum Genet (2003) 0.91

Ultrastructural observations on the hair bulb melanocytes and melanosomes in acute alopecia areata. J Invest Dermatol (1990) 0.91

Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata. Genes Immun (2005) 0.90

Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata. J Invest Dermatol (2002) 0.90

Alopecia areata in families: association with the HLA locus. J Investig Dermatol Symp Proc (1999) 0.90

Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol (2000) 0.89

A biologist's reflections on dermatology. J Invest Dermatol (1971) 0.89

Transfer of alopecia areata in the human scalp graft/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response. Clin Immunol (2003) 0.89

Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients. J Autoimmun (2004) 0.89

Reduced expression of interleukin-2 decreases the frequency of alopecia areata onset in C3H/HeJ mice. J Invest Dermatol (2005) 0.88

HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance. Arch Dermatol (1991) 0.88

Structure and function of cutaneous nerves in alopecia areata. J Invest Dermatol (1995) 0.88

Major histocompatibility complex class I chain-related gene A polymorphisms and extended haplotypes are associated with familial alopecia areata. J Invest Dermatol (2006) 0.88

Role of the autoimmune regulator (AIRE) gene in alopecia areata: strong association of a potentially functional AIRE polymorphism with alopecia universalis. Tissue Antigens (2002) 0.87

Treatment with an anti-CD44v10-specific antibody inhibits the onset of alopecia areata in C3H/HeJ mice. J Invest Dermatol (2000) 0.87

Hair growth in scalp grafts from patients with alopecia areata and alopecia universalis grafted onto nude mice. Arch Dermatol (1987) 0.86

Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction. Eur J Immunogenet (2002) 0.86

DR, DQ, and you: MHC alleles and autoimmunity. J Clin Invest (2001) 0.85

The genetic epidemiology of alopecia areata in China. Br J Dermatol (2004) 0.85

Restoration of hair growth with topical diphencyprone in mouse and rat models of alopecia areata. J Am Acad Dermatol (2003) 0.85

Association of HLA class I alleles with aloplecia areata in Chinese Hans. J Dermatol Sci (2005) 0.85

Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin. Exp Dermatol (2004) 0.85

Failure of passive transfer of serum from patients with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp skin grafted on to nude mice. Br J Dermatol (1992) 0.84

An updated survey on skin conditions in Down syndrome. Dermatology (2002) 0.84

The non-synonymous C1858T substitution in the PTPN22 gene is associated with susceptibility to the severe forms of alopecia areata. Hum Immunol (2006) 0.84

HLA class II alleles in patients with alopecia areata. Eur J Dermatol (2002) 0.83

Oral cyclosporin A restores hair growth in the DEBR rat model for alopecia areata. Clin Exp Dermatol (1995) 0.83

MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. J Invest Dermatol (1998) 0.83

Immunology: protection and privilege. Nature (2006) 0.82

Hair follicle structures targeted by antibodies in patients with alopecia areata. Arch Dermatol (1997) 0.82

The DEBR rat, alopecia areata and autoantibodies to the hair follicle. Br J Dermatol (1996) 0.82

Association of HLA-DQA1 and DQB1 alleles with alolpecia areata in Chinese Hans. Arch Dermatol Res (2005) 0.81

IFN-gamma-induced HLA-DR but not ICAM-1 expression on cultured dermal papilla cells is downregulated by TNF-alpha. Arch Dermatol Res (1997) 0.81

Partial restoration of hair growth in the DEBR model for Alopecia areata after in vivo depletion of CD4+ T cells. Br J Dermatol (1999) 0.80

Growth factor mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. Acta Derm Venereol (1996) 0.79

Histopathology of non-scarring alopecia. J Cutan Pathol (1995) 0.79

A chronic contact eczema impedes migration of antigen-presenting cells in alopecia areata. J Invest Dermatol (2006) 0.78

Investigation of the p.Ser278Arg polymorphism of the autoimmune regulator (AIRE) gene in alopecia areata. Tissue Antigens (2006) 0.78

Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice. J Investig Dermatol Symp Proc (2003) 0.78

Alopecia areata: the need for guidelines and evidence-based dermatology. Br J Dermatol (2005) 0.77

Response of grafts from patients with alopecia areata transplanted onto nude mice, to administration of interferon-gamma. Clin Immunol Immunopathol (1993) 0.77

Alopecia areata registry: an overview. J Investig Dermatol Symp Proc (2003) 0.77

No cell-surface-reactive antibodies against cultured autologous melanocytes found in alopecia areata sera. J Invest Dermatol (1995) 0.76

Earlier occurrence of severe alopecia areata in HLA-DRB1*11-positive patients. Dermatology (2006) 0.76

Mouse alopecia areata models: an array of data on mechanisms and genetics. J Investig Dermatol Symp Proc (2003) 0.76

The protective role of the HLA-DR locus in patients with various clinical types of alopecia areata. Arch Immunol Ther Exp (Warsz) (2002) 0.76

Articles by these authors

(truncated to the top 100)

Molecular principles of hair follicle induction and morphogenesis. Bioessays (2005) 3.08

Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature (2010) 2.85

Alopecia areata. N Engl J Med (2012) 2.56

The hair follicle as a dynamic miniorgan. Curr Biol (2009) 2.52

Exploring the "hair growth-wound healing connection": anagen phase promotes wound re-epithelialization. J Invest Dermatol (2010) 2.48

IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev (2006) 2.29

Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J (2005) 2.23

Reciprocal requirements for EDA/EDAR/NF-kappaB and Wnt/beta-catenin signaling pathways in hair follicle induction. Dev Cell (2009) 2.17

Cdc42 controls progenitor cell differentiation and beta-catenin turnover in skin. Genes Dev (2006) 2.10

IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat Med (2007) 2.00

Hair follicle pigmentation. J Invest Dermatol (2005) 1.84

Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol (2006) 1.72

Retracted A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control. EMBO J (2005) 1.72

Neuroimmunology of stress: skin takes center stage. J Invest Dermatol (2006) 1.72

The interleukin-15/interleukin-15 receptor system as a model for juxtacrine and reverse signaling. Bioessays (2006) 1.70

NF-kappaB transmits Eda A1/EdaR signalling to activate Shh and cyclin D1 expression, and controls post-initiation hair placode down growth. Development (2006) 1.66

Neuronal plasticity of the "brain-skin connection": stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways. J Mol Med (Berl) (2007) 1.58

Cylindroma as tumor of hair follicle origin. J Invest Dermatol (2006) 1.56

Mast cells are required for normal healing of skin wounds in mice. FASEB J (2006) 1.50

Circadian clock genes contribute to the regulation of hair follicle cycling. PLoS Genet (2009) 1.49

Beyond wavy hairs: the epidermal growth factor receptor and its ligands in skin biology and pathology. Am J Pathol (2008) 1.47

Immune-mediated loss of transgene expression in skin: implications for cutaneous gene therapy. Mol Ther (2003) 1.44

Immunophenotyping of the human bulge region: the quest to define useful in situ markers for human epithelial hair follicle stem cells and their niche. Exp Dermatol (2008) 1.43

Thyrotropin-releasing hormone selectively stimulates human hair follicle pigmentation. J Invest Dermatol (2011) 1.43

Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev (2005) 1.36

Molecular biology of hair morphogenesis: development and cycling. J Exp Zool B Mol Dev Evol (2003) 1.36

Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol (2006) 1.33

Plasticity and cytokinetic dynamics of the hair follicle mesenchyme: implications for hair growth control. J Invest Dermatol (2003) 1.32

A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control. Am J Pathol (2005) 1.27

Migration of melanoblasts into the developing murine hair follicle is accompanied by transient c-Kit expression. J Histochem Cytochem (2002) 1.26

Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol (2004) 1.24

Runx1 directly promotes proliferation of hair follicle stem cells and epithelial tumor formation in mouse skin. Mol Cell Biol (2010) 1.23

Exploring the role of stem cells in cutaneous wound healing. Exp Dermatol (2009) 1.23

Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol (2003) 1.22

Developmental timing of hair follicle and dorsal skin innervation in mice. J Comp Neurol (2002) 1.20

The mesenchymal component of hair follicle neogenesis: background, methods and molecular characterization. Exp Dermatol (2009) 1.20

Melatonin in the skin: synthesis, metabolism and functions. Trends Endocrinol Metab (2007) 1.20

Skin as an endocrine organ: implications for its function. Drug Discov Today Dis Mech (2008) 1.19

Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol (2007) 1.18

Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin. FASEB J (2003) 1.17

p75 Neurotrophin receptor antagonist retards apoptosis-driven hair follicle involution (catagen). J Invest Dermatol (2003) 1.16

Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses. Eur J Immunol (2003) 1.16

Thyroid hormones directly alter human hair follicle functions: anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation. J Clin Endocrinol Metab (2008) 1.15

Retracted Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-kappa B. J Biol Chem (2002) 1.15

Lhx2 differentially regulates Sox9, Tcf4 and Lgr5 in hair follicle stem cells to promote epidermal regeneration after injury. Development (2011) 1.15

Alopecia areata induced in C3H/HeJ mice by interferon-gamma: evidence for loss of immune privilege. J Invest Dermatol (2005) 1.13

Hair growth inhibition by psychoemotional stress: a mouse model for neural mechanisms in hair growth control. Exp Dermatol (2006) 1.13

Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit. Proc Natl Acad Sci U S A (2011) 1.13

Hair follicle stem cells: walking the maze. Eur J Cell Biol (2007) 1.12

The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling. Am J Pathol (2002) 1.11

How a cytokine is chaperoned through the secretory pathway by complexing with its own receptor: lessons from interleukin-15 (IL-15)/IL-15 receptor alpha. Mol Cell Biol (2008) 1.11

Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control. Bioessays (2007) 1.11

FOXN1 is critical for onycholemmal terminal differentiation in nude (Foxn1) mice. J Invest Dermatol (2004) 1.10

Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity (2009) 1.10

Interleukin-21 inhibits dendritic cell-mediated T cell activation and induction of contact hypersensitivity in vivo. J Invest Dermatol (2003) 1.10

The pathogenesis of primary cicatricial alopecias. Am J Pathol (2010) 1.09

From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch. Neuroimmunomodulation (2007) 1.07

Activation of transient receptor potential vanilloid-3 inhibits human hair growth. J Invest Dermatol (2011) 1.05

A role of melatonin in neuroectodermal-mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptors. FASEB J (2005) 1.03

The mitochondrial electron transport chain is dispensable for proliferation and differentiation of epidermal progenitor cells. Stem Cells (2011) 1.03

A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamide-induced alopecia in mice. J Invest Dermatol (2005) 1.03

Survival and migration of human dendritic cells are regulated by an IFN-alpha-inducible Axl/Gas6 pathway. J Immunol (2009) 1.03

Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair. Exp Dermatol (2008) 1.03

TRP channels as novel players in the pathogenesis and therapy of itch. Biochim Biophys Acta (2007) 1.02

Methods in hair research: how to objectively distinguish between anagen and catagen in human hair follicle organ culture. Exp Dermatol (2009) 1.02

Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone. J Invest Dermatol (2008) 1.01

Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol (2004) 1.01

Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition. J Mol Med (Berl) (2005) 1.01

Overexpression of mIGF-1 in keratinocytes improves wound healing and accelerates hair follicle formation and cycling in mice. Am J Pathol (2008) 1.01

Vanilloid receptor-1 (VR1) is widely expressed on various epithelial and mesenchymal cell types of human skin. J Invest Dermatol (2004) 1.01

Autoimmune disease induction in a healthy human organ: a humanized mouse model of alopecia areata. J Invest Dermatol (2012) 1.00

Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J Invest Dermatol (2005) 0.99

Towards the development of a simplified long-term organ culture method for human scalp skin and its appendages under serum-free conditions. Exp Dermatol (2007) 0.99

The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol Sci (2009) 0.99

Transient receptor potential vanilloid-1 signaling as a regulator of human sebocyte biology. J Invest Dermatol (2008) 0.99

Learning from nudity: lessons from the nude phenotype. Exp Dermatol (2005) 0.99

The hair follicle as an estrogen target and source. Endocr Rev (2006) 0.99

'Fish matters': the relevance of fish skin biology to investigative dermatology. Exp Dermatol (2010) 0.99

Sebocytes, multifaceted epithelial cells: lipid production and holocrine secretion. Int J Biochem Cell Biol (2009) 0.98

Bone morphogenetic protein signaling regulates postnatal hair follicle differentiation and cycling. Am J Pathol (2004) 0.98

Human hair follicles are an extrarenal source and a nonhematopoietic target of erythropoietin. FASEB J (2007) 0.98

Kit is expressed by epithelial cells in vivo. J Invest Dermatol (2003) 0.98

A practical guide for the study of human and murine sebaceous glands in situ. Exp Dermatol (2013) 0.97

Probing the effects of stress mediators on the human hair follicle: substance P holds central position. Am J Pathol (2007) 0.97

Activin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentration-dependent manner via keratinocytes. Am J Pathol (2005) 0.97

Neurotrophins in skin biology and pathology. J Invest Dermatol (2006) 0.97

Zinc as an ambivalent but potent modulator of murine hair growth in vivo- preliminary observations. Exp Dermatol (2005) 0.96

An unexpected twist in alopecia areata pathogenesis: are NK cells protective and CD49b+ T cells pathogenic? Exp Dermatol (2010) 0.96

A human folliculoid microsphere assay for exploring epithelial- mesenchymal interactions in the human hair follicle. J Invest Dermatol (2008) 0.96

Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors. J Invest Dermatol (2002) 0.95

Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. Am J Pathol (2004) 0.95

Highly complex peptide aggregates of the S100 fused-type protein hornerin are present in human skin. J Invest Dermatol (2008) 0.95

Lichen planopilaris is characterized by immune privilege collapse of the hair follicle's epithelial stem cell niche. J Pathol (2013) 0.95

The cycling hair follicle as an ideal systems biology research model. Exp Dermatol (2010) 0.95

Thyrotropin releasing hormone (TRH): a new player in human hair-growth control. FASEB J (2009) 0.95

Plasticity and cytokinetic dynamics of the hair follicle mesenchyme during the hair growth cycle: implications for growth control and hair follicle transformations. J Investig Dermatol Symp Proc (2003) 0.95

Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice. Arch Dermatol (2002) 0.95

Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1. J Invest Dermatol (2011) 0.94

Endocannabinoids limit excessive mast cell maturation and activation in human skin. J Allergy Clin Immunol (2012) 0.94

Retracted Mast cells express novel functional IL-15 receptor alpha isoforms. J Immunol (2003) 0.94